Related Experiment Video
Updated: Jun 25, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
DEC1 deficiency protects against bone loss induced by ovariectomy by inhibiting inflammation
Lan Lin1, Zhiyi Qiang1, Kaiao Chen1
1Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Abstract:
Studies have shown that differentiated embryo-chondrocyte expressed gene 1 (DEC1) promotes osteoblast osteogenesis. To investigate the role of DEC1 in postmenopausal osteoporosis, we used the two genotypes of mice ( Dec1 +/+ and Dec1 -/-) to establish an ovariectomy model and found that the bone loss was significantly lower in Dec1 -/- ovariectomy mice than in Dec1 +/+ ovariectomy mice. The expression levels of RUNX2 and OSX were significantly increased in Dec1 -/- ovariectomy mice, compared with Dec1 +/+ ovariectomy mice; however, the expression levels of NFATc1, c-Fos, CTSK, and RANKL/OPG ratio were significantly decreased in Dec1 -/- ovariectomy mice, compared with those in Dec1 +/+ ovariectomy mice. Likewise, DEC1 deficiency also suppressed the expression levels of IL-6 and IL-1β. Further results showed that the mRNA expression levels of Runx2, Osx, and Alp were significantly increased in bone marrow mesenchymal stem cells of Dec1 -/- ovariectomy mice, compared with those of Dec1 +/+ ovariectomy mice. Moreover, the mRNA levels of Il1b, Il6, Tnfa, and Ifng were significantly increased in bone marrow-derived macrophages (BMMs) of Dec1 +/+ovariectomy mice, compared with those of Dec1 +/+ sham mice, but not in Dec1 -/- ovariectomy BMMs, when compared with those in Dec1 -/- sham BMMs. Additionally, the expression levels of p-IκBα and p-P65 were significantly increased in Dec1 +/+ ovariectomy BMMs, compared with those in Dec1 +/+ sham BMMs, but did not increase in Dec1 -/- ovariectomy BMMs, compared with those in Dec1 -/- sham BMMs. Taken together, DEC1 deficiency inhibited the NF-κB pathway induced by ovariectomy, thereby decreasing cytokines and subsequently inhibiting the decrease of osteogenesis and the increase of osteoclastogenesis caused by ovariectomy. The findings may provide a novel understanding of postmenopausal osteoporosis development, and offer potential avenues for the disease intervention.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...